Neomycin And Polymyxin B Sulfates And Dexamethasone
Product Images NDC 67296-0435

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Neomycin And Polymyxin B Sulfates And Dexamethasone (NDC 67296-0435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neo-polyb-dex-suspension-5ml (Neo Polyb Dex Suspension 5ml)

Neo-polyb-dex-suspension-5ml (Neo Polyb Dex Suspension 5ml)
Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension 5 mL sterile bottle packaging label. The label includes the proprietary name, dosage form, volume, and indicates Rx only. Manufactured by Alcon Laboratories and Sandoz, with storage and usage warnings, ingredients per mL, and barcode visible. The label contains directions to shake well before use and keep out of reach of children.*
FDA Label Image

Dexamethasone-chemical (Dexamethasone Chemical)

Dexamethasone-chemical (Dexamethasone Chemical)
Chemical structure diagram illustrating the molecular composition of the active ingredient in Neomycin and Polymyxin B Sulfates and Dexamethasone. The structure depicts ring formations and functional groups consistent with a corticosteroid, likely representing dexamethasone.*
FDA Label Image

Neomycin-chemical (Neomycin)

Neomycin-chemical (Neomycin)
Chemical structure of Neomycin, an active ingredient in Neomycin and Polymyxin B Sulfates and Dexamethasone by Redpharm Drug.*
FDA Label Image

Polymyxin-chemical (Polymyxinb)

Polymyxin-chemical (Polymyxinb)
Chemical structure diagram showing the peptide sequences and side chain variations of Polymyxin B components, including Polymyxin B1, B2, B3, and B1-l. The structure highlights residues such as L-DAB (2,4-diaminobutanoic acid), L-Thr, D-Phe, and specifies differences in R, R', and X groups in a table format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.